Virtual

Join a workshop series led by Harvard Innovation Labs leaders, Troy Norris and Dr. Michael Fenn, as they discuss the importance of building a strong team and creating a culture early on in the venture building process. They will explore the challenges of bringing on co-founders and hiring your first employees and introduce how to build an operating plan and establishing KPIs.

Virtual

Apps for health, wellness and disease management are increasingly common across the healthcare ecosystem. This webinar will discuss emerging lessons and concepts from this space. What is the practical significance of the designation “digital therapeutic?” What are the current regulatory pathways? How does reimbursement actually work? Megan Jones Bell, MD, Chief Science Officer for Headspace, will discuss examples of how these interventions are being integrated into health care and some of the developments on the horizon for this industry.

Virtual

Humans have struggled with epidemics for as long as we have lived in cities. Dr. David Jones, A. Bernard Ackerman Professor of the Culture of Medicine at HMS, and Dr. Paul Farmer, will discuss the history of epidemics and how human societies respond. What lessons does this history offer? This talk will explore what we can learn from Covid’s historical precedents, and what remains uncertain.

Virtual

Addiction is one of numerous public health crises facing the US today. Treatment for severe substance use disorders (i.e., addiction) has evolved over time as science has advanced to better understand addiction as a chronic disease, acceptance of evidence-based practice guidelines, and availability of safe and effective treatments. Patients, however, still face barriers to engaging treatment for a variety of reasons (e.g., cost, stigma, limited resources), some of which will be explored in greater depth in this session. Thus, efforts to craft better policies that improve access to and affordable care for substance use disorder treatments are important.

Virtual

This Harvard Innovation Labs workshop series are hosted by Troy Norris and Dr. Michael Fenn. They will discuss how to build a fundraising roadmap and target investor list. Learn fundraising strategies and the different types of capital available for startups. They will also discuss how to effectively communicate with investors. Finally, we will have several investors on hand to talk about what they look for when evaluating startups, as well as how to prepare for your investor pitch.

Virtual

Historically people with disabilities have been stigmatized and excluded from social opportunities on a variety of culturally specific grounds. In this collection, the authors explore the impact that the philosophical framing of disability can have on public policy questions, in the clinic, in the courtroom, and elsewhere. You're invited to join the discussion.

Virtual

Join a discussion with Andrew Kress, co-founder and CEO, HealthVerity, Inc., on innovations in real-world data evidence and how they can be utilized to drive effective health economics and outcomes research decision-making, the challenges that can arise, and potential solutions to help resolve them. He will also discuss data management and interoperability under HIPAA including the accurate matching and linking of de-identified data across different ecosystems and data providers. Registration required.

Virtual

David Willbrand, Chair of the Early Stage & Emerging Company practice group at Thompson Hine LLP (and a Harvard alum), will present matters of startup capitalization focused towards If you are a founder or entrepreneur. He takes the mystery out of the jargon, explaining in accessible language what a cap table is, how it comes together, how it evolves and, most importantly, how startups raise money!

Virtual

Part of the Harvard Innovation Labs series, Troy Norris and Dr. Michael Fenn, will discuss the components and criteria of a winning pitch. They will also look at how to custom tailor your pitch for different audiences. Examples of pitch decks will be critically examined. Learn how to create a venture story and begin building a brand around your early-stage life science/healthcare company.

Virtual

Led by Troy Norris and Dr. Michael Fenn, founders will have an opportunity to give 5-10 min pitches incorporating what they have learned throughout this term's Life Science Business Development Sorkshop Series. Founders will receive critical feedback from peers and from the workshop leaders in a low pressure session.

Virtual

Join Heidrick & Struggles exectutives, Tim Dietlin, Global Managing Partner Healthcare and Life and Michael Hirshman, Principal, as they discuss a broad range of topics around an executive's path to being a first-time CEO. What does a typical search look like? What determines the phenotype of CEO being sought? What patterns and key experiences can help position a rising executive for success? Finally, is the CEO role even the one to aim for?

HLS, Wasserstein Hall, Milstein East

New regulations in the EU and the experiences of the FDA in the United States suggest that medical device regulation overall faces some global challenges, including the correct balance between patient protection and avoiding stifling business and innovation, the changing nature of medical devices to become increasingly software-based, and the difficulties of post-market surveillance. This conference will explore how these concerns can be expressed and successfully addressed in a variety of countries, each with a different medical device market.

Wasserstein Hall, Milstein East (2036) 1585 Massachusetts Ave. Cambridge, MA

Join us as we bring together federal-level government regulators of artificial intelligence technologies in North American, European, and Asian jurisdictions to highlight efforts around the globe to appropriately regulate the use of AI technologies in health care. The assembled regulators will discuss their initiatives in this area along with the challenges of regulating this unique and rapidly developing field.